Showing results (471-480 of 2,509) with videos related to
Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|February 27, 2023
Distinctive Attributes of Indian Patients With Classical BCR::ABL1 Negative Myeloproliferative Neoplasms: Unified Clinical and Laboratory DataSuvir Singh, Jagdeep Singh, Arpan Mehta, et al.Clinical Lymphoma, Myeloma & Leukemia|August 22, 2022
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell LymphomaSang Eun Yoon, Junhun Cho, Yeon Jeong Kim, et al.Clinical Lymphoma, Myeloma & Leukemia|August 16, 2022
Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or StrokeAnna Narezkina, Nausheen Akhter, Xiaoxiao Lu, et al.Clinical Lymphoma, Myeloma & Leukemia|August 30, 2021
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline ConsortiumRichard LeBlanc, Debra J Bergstrom, Julie Côté, et al.Clinical Lymphoma, Myeloma & Leukemia|August 7, 2022
Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma PatientsGulrayz Ahmed, Bhavna Bhasin-Chhabra, Aniko Szabo, et al.Clinical Lymphoma, Myeloma & Leukemia|August 9, 2022
High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor MicroenvironmentsNicolas Fernandez, Deepak Perumal, Adeeb Rahman, et al.Clinical Lymphoma, Myeloma & Leukemia|August 1, 2022
Retrospective Analysis of the Efficacy and Tolerability of Gemcitabine-Based Chemotherapy in Relapsed/Refractory Lymphoma Patients Not Eligible for Stem Cell TransplantMay Chiu, Samuel Hague, Anna Elinder-Camburn, et al.Clinical Lymphoma, Myeloma & Leukemia|March 16, 2023
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline ConsortiumJulie Côté, Rami Kotb, Debra J Bergstrom, et al.Clinical Lymphoma, Myeloma & Leukemia|March 16, 2023
SOHO State-of-the-Art Updates and Next Questions | BCMA-Directed CAR T-Cells: Early Results and Future DirectionsEden Biltibo, Jesus G BerdejaClinical Lymphoma, Myeloma & Leukemia|March 18, 2023
SOHO State of the Art Updates and Next Questions | Update on Treatment-Free Remission in Chronic Myeloid Leukemia (CML)Sherrie Mikhaeel, Ehab AtallahPageof 251